IRIS
CITRARO, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.527
AS - Asia 3.091
EU - Europa 1.928
SA - Sud America 605
Continente sconosciuto - Info sul continente non disponibili 286
AF - Africa 85
OC - Oceania 36
Totale 11.558
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.245
SG - Singapore 1.296
IT - Italia 938
CN - Cina 683
BR - Brasile 465
VN - Vietnam 284
DE - Germania 274
IN - India 261
CA - Canada 209
BD - Bangladesh 167
GB - Regno Unito 167
FI - Finlandia 146
HK - Hong Kong 128
SE - Svezia 114
NL - Olanda 55
AR - Argentina 46
MX - Messico 40
ID - Indonesia 35
AU - Australia 34
JP - Giappone 34
FR - Francia 32
ES - Italia 28
IQ - Iraq 27
TR - Turchia 27
ZA - Sudafrica 26
RU - Federazione Russa 25
EC - Ecuador 23
UA - Ucraina 23
CO - Colombia 22
PK - Pakistan 18
PL - Polonia 18
UZ - Uzbekistan 18
SA - Arabia Saudita 16
CL - Cile 15
CZ - Repubblica Ceca 15
IL - Israele 15
RO - Romania 13
GR - Grecia 12
PH - Filippine 12
VE - Venezuela 12
IR - Iran 11
EG - Egitto 9
MA - Marocco 9
AT - Austria 8
CH - Svizzera 8
KR - Corea 8
PY - Paraguay 8
CR - Costa Rica 7
MT - Malta 7
PE - Perù 7
SC - Seychelles 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
HR - Croazia 6
KE - Kenya 6
TN - Tunisia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DO - Repubblica Dominicana 5
EE - Estonia 5
JM - Giamaica 5
JO - Giordania 5
KZ - Kazakistan 5
MY - Malesia 5
PT - Portogallo 5
TW - Taiwan 5
HN - Honduras 4
LT - Lituania 4
NG - Nigeria 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AF - Afghanistan, Repubblica islamica di 3
AO - Angola 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
IE - Irlanda 3
LK - Sri Lanka 3
NP - Nepal 3
SN - Senegal 3
AL - Albania 2
CY - Cipro 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 11.266
Salva come PNG Salva come JPEG
Città #
San Jose 903
Singapore 523
Ashburn 455
Chandler 430
Dallas 369
Santa Clara 241
Munich 230
Council Bluffs 182
Milan 176
Bengaluru 169
Hefei 166
Beijing 158
Princeton 134
Catanzaro 128
Lawrence 128
Hong Kong 120
Chicago 103
Ottawa 100
Ho Chi Minh City 99
London 95
New York 83
Los Angeles 80
Wilmington 78
Phoenix 77
Turku 69
Helsinki 68
Hanoi 52
Boardman 48
Des Moines 44
São Paulo 44
Catania 43
Rome 41
Orem 36
Montreal 34
Brooklyn 31
Redwood City 31
Tokyo 28
Atlanta 25
Amsterdam 24
San Francisco 24
Palermo 23
Toronto 23
Shanghai 22
The Dalles 22
Haiphong 21
Naples 21
Boston 20
Denver 19
Chennai 18
Florence 17
Rio de Janeiro 17
Guangzhou 16
Johannesburg 16
Tashkent 16
Buffalo 15
Da Nang 15
Mexico City 15
Melbourne 14
Norwalk 14
San Nicola Manfredi 13
Newark 12
Shenzhen 12
Stockholm 12
Warsaw 12
Aversa 11
Brasília 11
Olomouc 11
Bari 10
Istanbul 10
Messina 10
Sydney 10
Vancouver 10
Dhaka 9
Houston 9
Prato 9
Riyadh 9
Washington 9
Hải Dương 8
Madrid 8
Padova 8
Pune 8
Salt Lake City 8
Salvador 8
West Jordan 8
Ankara 7
Baghdad 7
Belo Horizonte 7
Biên Hòa 7
Bogotá 7
Bologna 7
Boydton 7
Bắc Giang 7
Campinas 7
Can Tho 7
Charlotte 7
Columbus 7
Curinga 7
Curitiba 7
Guayaquil 7
Jakarta 7
Totale 6.570
Salva come PNG Salva come JPEG
Nome #
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 377
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 263
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 161
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 148
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 139
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 138
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 136
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 131
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 128
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 124
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 116
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 111
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 106
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 98
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 98
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 96
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 95
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 95
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP 93
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 92
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 92
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 90
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 88
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 88
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 88
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 87
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy 85
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 85
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 84
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 83
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 82
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 81
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 81
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 81
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 79
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 79
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 79
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 78
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 78
Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 77
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 77
Assessing Gender Differences in Neuropathic Pain Management: Findings from a Real-Life Clinical Cross-Sectional Observational Study 76
The potential role of cannabinoids in epilepsy treatment. 75
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence 74
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 74
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 74
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 74
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 73
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 73
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  73
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 73
Vasostatin-1 restores autistic disorders in an idiopathic autism model (BTBR T+ Itpr3tf/J mice) by decreasing hippocampal neuroinflammation 72
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 71
A questionnaire-based study on prevalence and treatments of headache in Secondary Schools people of Catanzaro 71
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 71
Epidemiology and outcomes of status epilepticus 71
Long-Term High-Fat Diet Aggravates Absence Seizures and Neurobehavioral Disorders Without Inducing Metabolic Disorders in WAG/Rij Rats: Involvement of Systemic and Central Inflammation 70
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 70
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells (CO-FIRST AUTHOR) 70
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 69
Pharmacokinetic considerations about antiseizure medications in the elderly 69
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 68
A Multiple Synergic Treatment for Non-Healing Ulcer Management in a Patient with Klippel–Trenaunay Syndrome 67
Direct Modulation of High-Frequency Neural Oscillations in the Auditory Cortex Through Electrical Microstimulation Generated by PVDF Sensors 67
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats 67
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 67
Antidepressants drugs for seizures and epilepsy: Where do we stand? 66
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo 66
Microbiota-gut brain axis involvement in neuropsychiatric disorders 65
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 65
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 64
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 64
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity 64
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures. Expert Opin Pharmacother. 2014 Jan 17. [Epub ahead of print] PubMed PMID: 24437529. 64
An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists 63
Nano‐hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: A pilot study 62
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 62
An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy 62
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 61
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 61
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 61
Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis 61
Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists 61
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis 61
Colchicine in Managing Skin Conditions: A Systematic Review 61
Metalloproteases in Pain Generation and Persistence: A Possible Target? 60
Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy? 60
Statins and Epilepsy: Preclinical Studies, Clinical Trials and Statin-Anticonvulsant Drug Interactions 60
Immediate and controlled-release pregabalin for the treatment of epilepsy 60
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 60
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region 59
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders 59
Oxygen–Ozone Therapy in Cervicobrachial Pain: A Real-Life Experience 58
Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats 58
Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence 58
Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis 57
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy 57
Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs 56
Biomimetic Sonar for Electrical Activation of the Auditory Pathway 56
Corrigendum to "Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice)" (DOI:10.1016/j.neuropharm.2005.04.012) 56
Totale 8.334
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.861
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022417 0 0 0 92 21 14 7 84 79 50 58 12
2022/20231.248 263 101 48 109 120 102 15 81 191 86 91 41
2023/2024734 120 90 63 61 54 121 31 46 11 47 29 61
2024/20252.141 262 71 105 90 143 262 161 94 237 71 266 379
2025/20265.210 303 448 556 674 512 244 653 256 636 422 308 198
2026/20271.215 105 308 554 248 0 0 0 0 0 0 0 0
Totale 11.558